Study | Running/control data | Bone (re)modelling markers | Assay used | Exercise duration/intensity |
---|---|---|---|---|
Evans et al. [15] | Control | β-CTX-1 P1NP | CLIA (IDS) CLIA (IDS) | – |
Lehrskov et al. [32] | Running and control | β-CTX-1 P1NP | CLIA (IDS) CLIA (IDS) | 60 min at 75% V̇O2max |
Sale et al. [24] | Running | β-CTX-1 P1NP | ECLIA (Roche) ECLIA (Roche) | 120 min at 70% V̇O2max |
Scott et al. [16] | Control | β-CTX-1 P1NP | ECLIA (Roche) RIA (Orion) | - |
Scott et al. [33] | Running | β-CTX-1 P1NP | ECLIA (Roche) RIA (Orion) | 60 min at 65% or 75% V̇O2max |
Scott et al. [23] | Running and control | β-CTX-1 P1NP | ECLIA (Roche) RIA (Orion) | 60 min at 65% V̇O2max |
Townsend et al. [25] | Running | β-CTX-1 P1NP | ECLIA (Roche) ECLIA (Roche) | ∼75 min at 75% V̇O2max |
Varley [29] | Running | β-CTX-1 | ELISA (IDS) | 120 min at 70% V̇O2max |